Total Revenues up 12.5% Year-Over-Year
Conference Call today at 4:30 p.m. ET 

NASHUA, N.H. (MAY 2, 2017) – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of
advanced image analysis, workflow solutions and radiation therapy for the early identification
and treatment of cancer, today reported financial results for the three-months ended March 31,

View Webcast

Full Results